Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety
NCT00241397
Last updated date
ABOUT THIS STUDY
The purpose of this study is to assess the prevalence of Major Depression and/or Anxiety
Disorder in patients consulting the General Practitioner with acute or chronic painful
physical symptoms and to identify risk factors.
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
By phone
Pfizer Clinical Trials Contact Center
1-800-718-1021
Eligibility Criteria
condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pain, Depression, Anxiety Disorder
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
Adult Trials: 18+ Years
18 + years
Inclusion Criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details
- Outpatient must be at least 18 years of age
- Consulting a General Practitioner for painful physical symptoms
- Written informed consent
Exclusion Criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details
- Patient is unable to understand and comply with procedures of the study
- Patient is unable to complete the patient ratings
- Patient has an acute pain with an obvious cause
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
Clinical Trials
Interested in learning more about clinical trials?
Discover how clinical trials work and the impact your participation could have.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
Pain, Depression, Anxiety DisorderStudy Evaluating Rhapsody Registry in Patients With Depression and Anxiety
NCT00241397
- Aarschot,
- Aiseau-Presles,
- Anderlues,
- Andrimont,
- Angleur,
- Ans,
- Anthée,
- Auvelais,
- Avelgem,
- Beauraing,
- Beernem,
- Bekegem-Ichtegem,
- Belgrade,
- Bertogne,
- Betekom,
- Bierges,
- Binche,
- Bioul,
- Braine l'Alleud,
- Brugge,
- Brugge,
- Brussel,
- Bruxelles,
- Bruxelles,
- Bruxelles,
- Bruxelles,
- Bruxelles,
- Bruxelles,
- Bruxelles,
- Bruxelles,
- Charleroi,
- Ciney,
- Couillet,
- Deurne (Antwerpen),
- Dworp,
- Eghezée,
- Eupen,
- Galmaarden,
- Goutroux,
- Grimminge,
- Hatrival,
- Hemiksem,
- Herenthout,
- Hoboken,
- Houdeng-Aimeries,
- Houdeng-Goegnies,
- Incourt,
- Itegem,
- Jabbeke,
- Jambes,
- Jodoigne,
- Kapellen,
- Kettenis,
- Klemskerke,
- Kuurne,
- Laarne,
- Lasne,
- Leuven,
- Lobbes,
- Luttre,
- Melin,
- Merksem,
- Monceau-sur-Sambre,
- Morlanwelz,
- Moustier S/S,
- Noorderwijk,
- Oudenaarde,
- Ranst,
- Reves,
- Rixensart,
- Romsee,
- Rotselaar,
- Ruddervoorde,
- Sainte-Marie-sur-Semois,
- Schildewindeke,
- Schoten,
- St-Joris Winge,
- Steenokkerzeel,
- Waarschoot,
- Waha,
- Walem,
- Wavre,
- Wetteren,
- Wevelgem,
- Wilrijk,
- Wommelgem,
- Wondelgem,
- Wuustwezel-Gooreind,
- Zelzate,
- Zemst,
- Zetrud-Lumay,
ALL GENDERS
18 Years+
years
MULTIPLE SITES
Advanced Information
| Descriptive Information | |||||||
|---|---|---|---|---|---|---|---|
| Brief Title | Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety | ||||||
| Official Title | An Observational Study on the Presence of Depression and/or Anxiety Disorder in Patients Consulting the General Practitioner With Painful Physical Symptoms in Belgium and Luxemburg. | ||||||
| Brief Summary | The purpose of this study is to assess the prevalence of Major Depression and/or Anxiety Disorder in patients consulting the General Practitioner with acute or chronic painful physical symptoms and to identify risk factors. | ||||||
| Detailed Description | Not Provided | ||||||
| Study Type | Observational | ||||||
| Study Design | Observational Model: Defined Population Time Perspective: Other | ||||||
| Target Follow-Up Duration | Not Provided | ||||||
| Biospecimen | Not Provided | ||||||
| Sampling Method | Not Provided | ||||||
| Study Population | Not Provided | ||||||
| Condition |
| ||||||
| Intervention | Not Provided | ||||||
| Study Groups/Cohorts | Not Provided | ||||||
| Publications * | Not Provided | ||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | |||||||
| Recruitment Information | |||||||
| Recruitment Status | Completed | ||||||
| Enrollment | 2560 | ||||||
| Original Enrollment | Same as current | ||||||
| Study Completion Date | Not Provided | ||||||
| Primary Completion Date | Not Provided | ||||||
| Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
| ||||||
| Sex/Gender |
| ||||||
| Ages | 18 Years and older (Adult, Older Adult) | ||||||
| Accepts Healthy Volunteers | No | ||||||
| Contacts | Contact information is only displayed when the study is recruiting subjects | ||||||
| Listed Location Countries | Belgium | ||||||
| Removed Location Countries | |||||||
| Administrative Information | |||||||
| NCT Number | NCT00241397 | ||||||
| Other Study ID Numbers | 0600B1-102003 | ||||||
| Has Data Monitoring Committee | Not Provided | ||||||
| U.S. FDA-regulated Product | Not Provided | ||||||
| IPD Sharing Statement | Not Provided | ||||||
| Responsible Party | Not Provided | ||||||
| Study Sponsor | Wyeth is now a wholly owned subsidiary of Pfizer | ||||||
| Collaborators | Not Provided | ||||||
| Investigators |
| ||||||
| PRS Account | Wyeth is now a wholly owned subsidiary of Pfizer | ||||||
| Verification Date | March 2007 | ||||||